Contents
pdf Download PDF
pdf Download XML
41 Views
11 Downloads
Share this article
Research Article | Volume 18 Issue 11 (November, 2026) | Pages 399 - 403
Antimicrobial Resistance in Complicated Urinary Tract Infections: A Retrospective Study in a Tertiary Care Hospital of Western Odisha
 ,
 ,
1
Associate professor, Department of Microbiology, BB Medical College And Hospital, Balangir, Odisha
2
Assistant professor, Department of Pharmacology, SRM Medical College And Hospital, Bhawanipatna
3
Associate professor, Department of Orthopaedics BB Medical College And Hospital, Balangir, Odisha
Under a Creative Commons license
Open Access
Received
Oct. 1, 2026
Revised
Oct. 24, 2026
Accepted
Nov. 2, 2026
Published
Nov. 19, 2026
Abstract

Introduction: Complicated urinary tract infections (cUTIs) present a formidable clinical challenge due to structural or functional urinary tract abnormalities combined with the escalating prevalence of antimicrobial resistance (AMR). Regional epidemiological data in Western Odisha remain sparse, complicating empirical therapeutic decisions. This study aimed to evaluate the bacteriological profile and AMR patterns of cUTIs at a tertiary care center. Methods: A retrospective, hospital-based observational study was conducted at Bhima Bhoi Medical College and Hospital (BB MCH), Balangir, Odisha, from January 2025 to January 2026. A total of 108 culture-positive urine samples from patients with cUTIs were analyzed. Pathogen identification and susceptibility testing were performed following CLSI guidelines. Risk factors for multi-drug resistance (MDR) were analyzed using chi-square tests, with a p-value of <0.05 deemed significant. Results: Gram-negative bacilli overwhelmingly dominated the profile (86.1%), with Escherichia coli (54.6%) and Klebsiella pneumoniae (18.5%) being the most prevalent. E. coli exhibited critical resistance to fluoroquinolones (74.6%) and third-generation cephalosporins (>79%). Carbapenem resistance was documented in 15.3% of E. coli isolates. Nitrofurantoin (18.6% resistance) and fosfomycin (11.9% resistance) retained high efficacy. Prior antibiotic use (p=0.002) and a history of catheterization (p=0.034) were significantly associated with the acquisition of MDR infections. Conclusion: The deeply concerning prevalence of MDR uropathogens in Western Odisha severely restricts the empirical utility of fluoroquinolones and cephalosporins. Nitrofurantoin and aminoglycosides offer reliable alternatives. Strict antimicrobial stewardship and tailored local antibiograms are urgently required to navigate this crisis.

Keywords
INTRODUCTION

Urinary tract infections (UTIs) remain one of the most frequently encountered bacterial infections globally, placing a substantial burden on both community and tertiary healthcare systems. While uncomplicated UTIs primarily affect healthy individuals, complicated urinary tract infections (cUTIs) occur in patients burdened by underlying anatomical or functional abnormalities. These complicating factors include urinary retention, indwelling urinary catheters, nephrolithiasis, immunosuppression, and obstructive uropathies such as benign prostatic hyperplasia (BPH). The presence of these factors dramatically increases the host's susceptibility to infection, compromises the eradication of invading pathogens, and frequently leads to severe clinical sequelae including persistent pyelonephritis, bacteremia, urosepsis, and elevated mortality rates.

 

The clinical management of cUTIs has become progressively precarious over the last two decades, driven by the global dissemination of antimicrobial resistance (AMR). The relentless ascent of AMR, particularly among the Enterobacteriaceae family, represents a profound health crisis. Uropathogens such as Escherichia coli and Klebsiella pneumoniae possess a notorious capacity to rapidly acquire and express resistance mechanisms, including Extended-Spectrum Beta-Lactamases (ESBLs) and carbapenemases. This enzymatic defense effectively nullifies core antibiotic classes, leaving clinicians with severely restricted therapeutic pathways. Furthermore, the co-selection of resistance to other agents frequently yields multi-drug resistant (MDR) phenotypes, compelling the use of older, more toxic antimicrobials or highly expensive novel combinations.

 

In developing nations, the AMR crisis is exacerbated by systemic vulnerabilities. Factors such as over-the-counter antibiotic availability, widespread self-medication, and empirical over-prescription in the absence of diagnostic facilities accelerate the proliferation of resistant strains. Western Odisha, characterized by its distinct demographic profile and specific healthcare challenges, is acutely affected. Bhima Bhoi Medical College and Hospital (BB MCH) in Balangir serves a vast, predominantly rural and tribal population. Delayed healthcare-seeking behavior often results in patients presenting with advanced, deeply rooted complicated infections.

 

In this resource-limited setting, physicians often rely on broad, non-localized guidelines that may fail to reflect the regional resistance landscape, precipitating treatment failures. Therefore, continuous epidemiological surveillance is critical. This retrospective study was designed to investigate the prevalence, bacteriological etiology, and AMR patterns of pathogens causing cUTIs at BB MCH, Balangir, over a one-year period, establishing a balanced, actionable foundation for evidence-based clinical practice.

MATERIALS AND METHODS

2.1 Study Design and Setting

This retrospective, hospital-based observational study was conducted within the Department of Microbiology, in close collaboration with the Department of General Medicine, at Bhima Bhoi Medical College and Hospital (BB MCH), Balangir, Western Odisha, India. The study spanned a complete 12-month cycle from January 2025 to January 2026. As a pivotal tertiary referral center, BB MCH caters to diverse demographic populations, offering a highly representative cohort for assessing regional infectious disease dynamics.

 

2.2 Study Population and Sample Size

The study incorporated patients across all age brackets and genders presenting with a clinical diagnosis of a complicated UTI. A cUTI was strictly defined by the presence of structural or functional genitourinary abnormalities, foreign bodies such as urinary catheters, or immunocompromising metabolic disorders like poorly controlled diabetes mellitus. Over the designated period, a total of 108 non-repetitive, consecutive, culture-positive urine samples meeting the cUTI criteria were selected. Samples demonstrating mixed bacterial growth or clinically insignificant colony counts were systematically excluded.

 

2.3 Data Collection and Microbiological Processing

Comprehensive demographic and clinical data—including age, gender, underlying comorbidities, history of recent hospital admissions, prior antibiotic usage within the preceding three months, and history of urinary catheterization—were meticulously extracted from medical records. Mid-stream or catheter-derived urine samples were cultured using the semi-quantitative surface streaking method on CLED and Blood agar. A colony count of ≥ 10^5 CFU/mL for mid-stream urine and ≥ 10^3 CFU/mL for catheterized urine indicated significant bacteriuria. Isolated pathogens were identified via standard biochemical protocols.

 

2.4 Antimicrobial Susceptibility Testing and Statistical Analysis

Antimicrobial susceptibility testing (AST) was executed using the Kirby-Bauer disk diffusion method on Mueller-Hinton agar, stringently adhering to the latest Clinical and Laboratory Standards Institute (CLSI) guidelines. Multi-drug resistance (MDR) was defined as acquired non-susceptibility to at least one agent in three or more distinct antimicrobial categories. The resulting data were compiled and analyzed using SPSS software version 26.0. The association between distinct clinical risk factors and MDR status was evaluated utilizing the Pearson Chi-square test, with a two-tailed p-value of less than 0.05 considered statistically significant.

 

RESULTS

The one-year retrospective analysis of the 108 culture-positive cUTI samples provided a clear, multifaceted view of the regional infection landscape. The findings are systematically categorized into demographics, microbial distribution, resistance patterns, and MDR risk factors to ensure a balanced, comprehensive overview.

3.1 Demographic Characteristics

Table 1 details the demographic framework of the study cohort. The patient population skewed heavily toward the elderly, with individuals over 60 years of age comprising 43.5% of the total cases. The mean age was 54.2 ± 16.8 years. The gender distribution revealed a notable male predominance, accounting for 63.0% (68 patients) compared to 37.0% (40 patients) females. This gender disparity correlates strongly with the age-related onset of obstructive uropathies, primarily benign prostatic hyperplasia, in older male patients.

 

Table 1: Demographic Characteristics of the Study Population (n = 108)

Characteristic

Number (n)

Percentage (%)

Age Group: < 40 Years

24

22.2

Age Group: 40 - 60 Years

37

34.3

Age Group: > 60 Years

47

43.5

Gender: Male

68

63.0

Gender: Female

40

37.0


3.2 Distribution of Uropathogens

The bacteriological isolation profile was overwhelmingly dominated by Gram-negative bacilli (GNB), which constituted 86.1% of the total isolates, while Gram-positive cocci (GPC) made up the remaining 13.9%. As illustrated in Table 2, Escherichia coli was the most frequently isolated pathogen, responsible for 54.6% of infections, closely followed by Klebsiella pneumoniae at 18.5%. Among the Gram-positive group, Enterococcus faecalis was the primary organism identified.

 

Table 2: Distribution of Isolated Uropathogens (n = 108)

Organism

Number (n)

Percentage (%)

Escherichia coli (GNB)

59

54.6

Klebsiella pneumoniae (GNB)

20

18.5

Pseudomonas aeruginosa (GNB)

10

9.2

Proteus mirabilis (GNB)

4

3.7

Enterococcus faecalis (GPC)

9

8.3

Staphylococcus aureus (GPC)

4

3.7

Coagulase-Negative Staph. (GPC)

2

1.9


3.3 Antimicrobial Resistance Patterns

The resistance profiles presented in Table 3 highlight critical therapeutic challenges. E. coli demonstrated severe resistance to staple empirical drugs: 74.6% to ciprofloxacin, 84.7% to amoxicillin-clavulanate, and 81.4% to cefotaxime. Shockingly, carbapenem resistance (meropenem) emerged in 15.3% of E. coli and 25.0% of K. pneumoniae isolates. Conversely, nitrofurantoin and fosfomycin retained high efficacy against E. coli. Table 4 demonstrates that while E. faecalis resisted ciprofloxacin heavily, all Gram-positive isolates remained uniformly susceptible to linezolid and vancomycin.

 

Table 3: Resistance Pattern of Major Gram-Negative Isolates (%)

Antibiotic

E. coli (n=59)

K. pneumoniae (n=20)

P. aeruginosa (n=10)

Amoxicillin-Clavulanate

84.7%

90.0%

NA

Cefotaxime

81.4%

85.0%

NA

Piperacillin-Tazobactam

28.8%

40.0%

10.0%

Meropenem

15.3%

25.0%

20.0%

Amikacin

20.3%

35.0%

10.0%

Ciprofloxacin

74.6%

65.0%

40.0%

Nitrofurantoin

18.6%

60.0%

NA

Fosfomycin

11.9%

30.0%

NA

 

Table 4: Resistance Pattern of Gram-Positive Isolates (%)

Antibiotic

E. faecalis (n=9)

S. aureus (n=4)

Ciprofloxacin

66.7%

50.0%

Erythromycin

77.8%

50.0%

Linezolid

0.0%

0.0%

Vancomycin

0.0%

0.0%


3.4 Risk Factors Associated with MDR Infection

Multi-drug resistant (MDR) phenotypes were observed in a staggering 72.2% (78/108) of the total isolates. Table 5 establishes the statistical correlation between clinical risk factors and the likelihood of MDR acquisition. A history of prior antibiotic use within three months was a remarkably strong predictor of MDR infection (p=0.002). Furthermore, a history of urinary catheterization significantly increased the probability of isolating an MDR pathogen (p=0.034).

 

Table 5: Clinical Risk Factors and MDR Infections (n=108)

Risk Factor

MDR (n=78)

Non-MDR (n=30)

p-value

Prior Antibiotic Use: Yes (n=44)

39 (88.6%)

5 (11.4%)

0.002*

Prior Antibiotic Use: No (n=64)

39 (59.4%)

25 (40.6%)

 

Urinary Catheterization: Yes (n=34)

29 (85.3%)

5 (14.7%)

0.034*

Urinary Catheterization: No (n=74)

49 (66.2%)

25 (33.8%)

 

Diabetes Mellitus: Yes (n=42)

34 (81.0%)

8 (19.0%)

0.125

Diabetes Mellitus: No (n=66)

44 (66.7%)

22 (33.3%)

 

* Statistically significant correlation (p < 0.05, Pearson Chi-square test).

DISCUSSION

The clinical landscape of complicated urinary tract infections is undergoing a dramatic transformation due to the rapid infiltration of MDR uropathogens. The findings from BB MCH, Balangir, present a sobering reflection of the changing microbial ecology in Western Odisha. The demographic distribution observed in our study—a strong male predominance coupled with a largely elderly cohort—perfectly parallels global epidemiological norms for cUTIs. This pattern is primarily driven by the age-related onset of obstructive prostatic pathologies and the consequent need for urinary instrumentation, which naturally predispose these patients to complex infections.

 

Bacteriologically, the overwhelming dominance of Gram-negative bacilli, specifically Escherichia coli and Klebsiella pneumoniae, underscores the persistent threat posed by the Enterobacteriaceae family. However, the most critical revelation of this study is the sheer magnitude of antimicrobial resistance harbored by these organisms. The foundational pillars of empirical UTI therapy—fluoroquinolones and third-generation cephalosporins—have been rendered functionally obsolete in this setting. With E. coli exhibiting over 74% resistance to ciprofloxacin and over 80% to cefotaxime, it is evident that ESBL-producing strains have firmly entrenched themselves in both the community and the hospital environment.

 

More alarmingly, the emergence of carbapenem resistance in 15.3% of E. coli and 25.0% of K. pneumoniae isolates constitutes a public health emergency. Carbapenems have historically served as the ultimate safeguard against severe ESBL infections. The rising incidence of carbapenem-resistant Enterobacteriaceae (CRE) within a regional tertiary center drastically narrows the therapeutic corridor, forcing a reliance on nephrotoxic agents like colistin or economically prohibitive novel antibiotics, a prospect that is unsustainable in resource-limited settings.

 

Despite this aggressive systemic resistance, older oral agents like nitrofurantoin and fosfomycin demonstrated a remarkable preservation of efficacy against E. coli. While these medications provide excellent avenues for step-down therapy or the management of localized cystitis, their pharmacokinetic limitations—namely poor tissue penetration—restrict their utility in treating systemic, complicated infections like pyelonephritis or urosepsis. Fortunately, intravenous amikacin and piperacillin-tazobactam maintained moderate reliability, serving as crucial inpatient options.

 

The statistical evaluation of MDR risk factors forcefully validated the principles of selective microbial pressure. Prior antibiotic exposure emerged as the strongest independent predictor for acquiring an MDR infection (p=0.002). This highlights the destructive consequence of indiscriminate antibiotic prescribing, which eradicates susceptible flora and cultivates resistant clones. Additionally, the significant association between urinary catheterization and MDR strains (p=0.034) reinforces the critical role of biofilm formation on foreign materials, which shields bacteria from both the host immune system and systemic antibiotics. The study's primary limitations lie in its retrospective nature and the absence of molecular genotyping to identify specific resistance genes (e.g., NDM-1 or OXA-48), which are vital for a complete epidemiological picture.

CONCLUSION

The empirical treatment paradigms for complicated urinary tract infections in Western Odisha require immediate and rigorous recalibration. The widespread obsolescence of fluoroquinolones and cephalosporins, combined with the chilling emergence of carbapenem resistance, dictates a mandatory shift toward highly nuanced, culture-guided therapeutic strategies. The strong statistical links bridging prior antibiotic exposure and catheterization to MDR phenotypes emphasize the non-negotiable need for robust antimicrobial stewardship. Routine updating of institutional antibiograms, strict rationalization of reserve antibiotics, and aggressive infection control protocols at BB MCH are imperative to safeguard the dwindling arsenal of effective antimicrobials.

REFERENCES
  1. Wagenlehner FME, Bjerklund Johansen TE, Cai T, et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol. 2020;17(10):586-600.
  2. World Health Organization (WHO). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022. Geneva: WHO; 2022.
  3. Taneja N, Sharma M. Antimicrobial resistance in the environment: The Indian scenario. Indian J Med Res. 2019;149(2):119-128.
  4. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. M100. Wayne, PA; 2024.
  5. Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017;129(2):242-258.
  6. Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents. 2011;37(4):291-295.
  7. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother. 2008;62 Suppl 1:i1-i9.
  8. Zilberberg MD, Nathanson BH, Sulham K, et al. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection. BMC Infect Dis. 2017;17(1):279.
  9. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe. Int J Antimicrob Agents. 2012;39(1):45-51.
  10. Das S, Barman P. Changing trend of antimicrobial resistance in complicated urinary tract infections in a tertiary care hospital of Eastern India. J Glob Antimicrob Resist. 2021;24:145-151.
  11. Patel J. Antibiotic Stewardship: The Indian Perspective. Indian J Med Microbiol. 2018;36(4):461-464.
  12. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults. Clin Infect Dis. 2010;50(5):625-663.
  13. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. Clin Infect Dis. 2011;52(5):e103-e120.
  14. Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents. 2012;39(4):283-294.
  15. Nicolle LE. Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol. 2005;16(6):349-360.
Recommended Articles
Research Article
Comparison of Left Ventricular Global Longitudinal Strain Between Diabetic Patients With And Without Microalbuminuria
...
Published: 17/11/2026
Research Article
Geriatric Neurosurgery: Need of Developing A Practice Protocol-Experience In A Tertiary Care Hospital Of Western Odisha
...
Published: 18/11/2026
Research Article
Predictive Value of Preoperative Platelet-to-Lymphocyte Ratio and Systemic Immune-Inflammation Index for Periprosthetic Joint Infection Following Total Knee Arthroplasty
...
Published: 17/11/2026
Research Article
Respiratory Symptoms and Spirometric Airflow Obstruction among Adult Smokers and Non-Smokers: A Comparative Cross-Sectional Study
Published: 18/11/2026
Chat on WhatsApp
© Copyright CME Journal Geriatric Medicine